CLINICAL_TRIALS
trial_result
· 2018-01-10
Clinical Trial Update: Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis [Phase 2]
Summary
Phase 2 study update for FK463 in candidemia or invasive candidiasis; the trial is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Candidiasis | Phase 2 | Status: COMPLETED